- Report
- August 2024
- 112 Pages
Global
From €4421EUR$4,650USD£3,714GBP
- Report
- October 2024
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- August 2024
- 120 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- June 2024
- 166 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- August 2024
- 140 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- May 2024
- 138 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- March 2025
- 306 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 193 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 166 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- January 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Clinical Trials
- April 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- April 2024
- 114 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- January 2025
- 250 Pages
Global
From €4752EUR$4,999USD£3,992GBP
- Report
- January 2025
- 250 Pages
Global
From €4752EUR$4,999USD£3,992GBP
- Report
- August 2024
- 240 Pages
Global
From €4705EUR$4,949USD£3,952GBP

Cellular Transplantation is a form of biotechnology that involves the transfer of cells from one organism to another. It is used to treat a variety of diseases and conditions, including cancer, diabetes, and heart disease. The process involves the extraction of healthy cells from a donor, which are then transplanted into the recipient. The transplanted cells can be used to replace damaged or diseased cells, or to stimulate the body's own immune system to fight off disease.
Cellular Transplantation is a rapidly growing field of biotechnology, with many potential applications. It has the potential to revolutionize the treatment of many diseases, and has already been used to treat a variety of conditions. It is also being explored as a potential treatment for neurological disorders, such as Parkinson's disease.
Companies in the Cellular Transplantation market include Novartis, Celgene, and Astellas Pharma. Other companies involved in the field include BioMarin Pharmaceuticals, Vertex Pharmaceuticals, and Kite Pharma. Show Less Read more